Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Advazorb Silfix Lite dressing 20cm x 20cm
20030900186
|
Advazorb Silfix Lite dressing 20cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Advil 200mg tablets
1001010J0CEAAAD
|
Advil | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Advil Extra Strength 400mg tablets
1001010J0CEABAE
|
Advil | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
AeroBec 100 Autohaler
0302000C0BEACAT
|
AeroBec | Beclometasone dipropionate | Respiratory System | No data available |
|
AeroBec 50 Autohaler
0302000C0BEAAAS
|
AeroBec | Beclometasone dipropionate | Respiratory System | No data available |
|
AeroBec Forte 250 Autohaler
0302000C0BEABAU
|
AeroBec | Beclometasone dipropionate | Respiratory System | No data available |
|
Aerocrom inhaler
0303010Q0BGAAAI
|
Aerocrom | Sodium cromoglicate | Respiratory System | No data available |
|
Aerocrom Syncroner with spacer
0303010Q0BGABAK
|
Aerocrom | Sodium cromoglicate | Respiratory System | No data available |
|
Aerodiol 150micrograms/dose nasal spray
0604011G0BSAABS
|
Aerodiol | Estradiol | Endocrine System | No data available |
|
Aerolin 100micrograms/dose Autohaler
0301011R0BKADAD
|
Aerolin | Salbutamol | Respiratory System | No data available |
|
Afatinib 20mg tablets
0801050BPAAACAC
|
Afatinib | Afatinib | Malignant Disease and Immunosuppression | No data available |
|
Afatinib 30mg tablets
0801050BPAAAAAA
|
Afatinib | Afatinib | Malignant Disease and Immunosuppression | No data available |
|
Afatinib 40mg tablets
0801050BPAAABAB
|
Afatinib | Afatinib | Malignant Disease and Immunosuppression | No data available |
|
Afatinib 50mg tablets
0801050BPAAADAD
|
Afatinib | Afatinib | Malignant Disease and Immunosuppression | No data available |
|
Afex briefs extra small
22902199039
|
Afex briefs extra small | Urinal Systems | Incontinence Appliances | No data available |
|
Afex Core Supporter briefs extra small
22902199047
|
Afex Core Supporter briefs extra small | Urinal Systems | Incontinence Appliances | No data available |
|
Afex Core Supporter male urinal system with extra small briefs
22902199040
|
Afex Core Supporter male urinal system with extra small briefs | Urinal Systems | Incontinence Appliances | No data available |
|
Afex Mobility Assisted male urinal system with extra large briefs
22902199009
|
Afex Mobility Assisted male urinal system with extra large briefs | Urinal Systems | Incontinence Appliances | No data available |
|
Afex Sedentary male urinal system with medium briefs
22902199013
|
Afex Sedentary male urinal system with medium briefs | Urinal Systems | Incontinence Appliances | No data available |
|
Afex Sedentary male urinal system with small briefs
22902199012
|
Afex Sedentary male urinal system with small briefs | Urinal Systems | Incontinence Appliances | No data available |
|
Afex Sedentary male urinal system with XXX large briefs
22902199017
|
Afex Sedentary male urinal system with XXX large briefs | Urinal Systems | Incontinence Appliances | No data available |
|
Afinitor 2.5mg tablets
0801050AXBBACAC
|
Afinitor | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Afinitor 5mg tablets
0801050AXBBAAAA
|
Afinitor | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Aflibercept 21mg/184microlitres inj pre-filled syringes
1108020AIAAAAAA
|
Aflibercept | Aflibercept | Eye | No data available |
|
Afrazine 0.05% nasal spray
1202020G0BBAAAA
|
Afrazine | Oxymetazoline hydrochloride | Ear, Nose and Oropharynx | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.